Dizziness

Disclaimer: This clinical reference is intended for healthcare professionals and provides general medical information based on current evidence. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions must always be made based on individual patient circumstances, incorporating clinical judgment and the latest available evidence. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to patient care.

Overview

• Definition: Dizziness is a non-specific term used by patients to describe a variety of sensations, most commonly categorized into four distinct types:
  1. Vertigo: A sensation of spinning or whirling, either of oneself or the surroundings. It implies a vestibular system dysfunction (peripheral or central).
  2. Presyncope: A sensation of impending faint or lightheadedness, often accompanied by pallor, sweating, nausea, and visual blurring. It indicates cerebral hypoperfusion, typically from cardiovascular or autonomic causes.
  3. Disequilibrium: A sensation of unsteadiness or imbalance, particularly when walking. It suggests dysfunction in vestibular, cerebellar, proprioceptive, or visual systems, or musculoskeletal issues.
  4. Non-specific Dizziness / Ill-defined Dizziness: A vague feeling of giddiness, swimming in the head, or a "fuzzy" sensation, often without a clear spinning or lightheaded component. Frequently associated with anxiety, depression, or somatization.
• Epidemiology:
  • One of the most common complaints in outpatient clinics, affecting approximately 15-20% of adults annually.
  • Prevalence increases with age, affecting up to 30% of individuals over 65 years. It is the most common complaint among individuals over 75 years of age.
  • More common in women than men.
  • Associated with significant morbidity, including falls, reduced quality of life, anxiety, depression, and decreased functional independence.
• Classification:
  • By Sensation: Vertigo, Presyncope, Disequilibrium, Non-specific Dizziness.
  • By Etiology:
    • Vestibular (Peripheral or Central): Benign Paroxysmal Positional Vertigo (BPPV), Vestibular Neuritis/Labyrinthitis, Meniere's Disease, Vestibular Migraine, Acoustic Neuroma, Superior Semicircular Canal Dehiscence, Bilateral Vestibulopathy, Perilymphatic Fistula, Central Vestibular Disorders (stroke, multiple sclerosis, brainstem lesions).
    • Cardiovascular: Orthostatic Hypotension, Arrhythmias, Vasovagal Syncope, Myocardial Infarction, Aortic Stenosis, Cardiomyopathy.
    • Neurological (Non-vestibular Central): Cerebellar ataxia, Peripheral Neuropathy, Parkinson's Disease, Stroke affecting non-vestibular pathways.
    • Psychiatric: Anxiety (Panic attacks, Generalized Anxiety Disorder), Depression, Somatic Symptom Disorder, Persistent Postural-Perceptual Dizziness (PPPD).
    • Metabolic/Systemic: Hypoglycemia, Anemia, Dehydration, Hypothyroidism.
    • Medication-Induced: Polypharmacy, Antihypertensives, Sedatives, Anticonvulsants, Ototoxic drugs (aminoglycosides).
    • Visual: Uncorrected refractive errors, cataracts, ocular muscle imbalance.
  • By Timing:
    • Acute Vestibular Syndrome (AVS): Acute onset, persistent vertigo (lasting days to weeks), often with nausea/vomiting, nystagmus, and gait instability.
    • Episodic Vestibular Syndrome (EVS): Recurrent episodes of vertigo, with symptom-free intervals.
    • Chronic Dizziness: Symptoms lasting >3 months, often multifactorial.

Pathophysiology

• Mechanism: Dizziness arises from a mismatch or disruption in the sensory information processed by the brain regarding body position and motion. The primary systems involved are:
  1. Vestibular System: Inner ear (semicircular canals, otolith organs) and its central connections in the brainstem and cerebellum. Provides information about head movement and gravity.
     • Peripheral Vestibular Dysfunction: Often leads to vertigo, nausea, and nystagmus that is typically unidirectional, suppressible by visual fixation, and associated with specific head positions or movements (e.g., BPPV, vestibular neuritis).
     • Central Vestibular Dysfunction: Involves brainstem or cerebellar lesions. Can cause vertigo, often with more prominent gait ataxia, nystagmus that may be multidirectional, purely vertical, or not suppressible by visual fixation, and other focal neurological signs (e.g., stroke, MS).
  2. Visual System: Provides information about the environment and head movement relative to surroundings. Visual input helps stabilize posture and gaze.
  3. Proprioceptive System: Sensory receptors in muscles, joints, and ligaments provide information about body position and movement. This input is crucial for balance and coordination, especially of the lower extremities.
  4. Cardiovascular System: Ensures adequate blood supply to the brain. Hypoperfusion (e.g., from orthostatic hypotension, arrhythmias) can lead to presyncope or lightheadedness.
  5. Cerebellar System: Integrates sensory information and coordinates motor control, crucial for maintaining balance and gait.
  6. Psychological Factors: Anxiety and fear can heighten sensory perception and contribute to symptoms, sometimes leading to a vicious cycle of dizziness and anxiety (e.g., PPPD).
• Risk Factors:
  • Age: Degenerative changes in vestibular system, sensory organs, cardiovascular system, and increased polypharmacy.
  • Female Sex: Higher incidence of vestibular migraine and BPPV.
  • Medical Comorbidities: Diabetes (neuropathy, autonomic dysfunction), Hypertension (orthostatic dysfunction, stroke risk), Cardiovascular Disease (arrhythmias, heart failure, atherosclerosis), Neurological Disorders (Parkinson's, MS, stroke history), Anxiety/Depression.
  • Medications: Polypharmacy (especially >4 medications), antihypertensives, sedatives, antidepressants, ototoxic drugs (aminoglycosides, loop diuretics, NSAIDs).
  • Sensory Deficits: Impaired vision, peripheral neuropathy.
  • Lifestyle: Dehydration, poor nutrition.
  • Previous Head Injury: Can lead to BPPV or post-concussion syndrome.
• Protective Factors:
  • Regular Exercise: Improves balance, proprioception, and cardiovascular fitness.
  • Management of Chronic Diseases: Strict control of blood pressure, blood glucose.
  • Medication Review: Regular assessment of medications, particularly in older adults, to identify and reduce potentially dizzying drugs or polypharmacy.
  • Good Hydration and Nutrition.
  • Vision Correction: Regular eye exams and updated prescriptions.

Clinical Presentation

Signs and Symptoms

• Cardinal Features: Crucial to distinguish the type of dizziness.
  • Vertigo: Spinning sensation (either the room or self), often with nausea, vomiting, and nystagmus.
    • Peripheral Vertigo: Often sudden onset, severe, associated with auditory symptoms (tinnitus, hearing loss), triggered by head movement, typically fatigable.
    • Central Vertigo: Often less severe spinning, prominent imbalance/ataxia, may have focal neurological deficits, nystagmus often non-fatigable, not suppressed by visual fixation, purely vertical/torsional.
  • Presyncope: Lightheadedness, feeling faint, "greying out" of vision, pallor, diaphoresis, nausea, palpitations. Occurs typically on standing or prolonged standing.
  • Disequilibrium: Unsteadiness, difficulty walking in a straight line, feeling off-balance. Usually worse with ambulation.
  • Non-specific Dizziness: Vague sensation of giddiness, "foggy," "swimming" head. Often associated with anxiety, hyperventilation, or poor sleep.
• Early Signs:
  • BPPV: Brief, recurrent episodes of vertigo triggered by specific head movements (e.g., turning in bed, looking up).
  • Vestibular Neuritis: Acute, sustained, severe vertigo often following a viral illness, with nausea/vomiting, imbalance, but no hearing loss.
  • Orthostatic Hypotension: Lightheadedness upon standing, often after prolonged lying/sitting.
  • Vestibular Migraine: Recurrent vertigo episodes, often with migrainous headache features (photophobia, phonophobia, aura), but vertigo can occur without headache.
• Advanced Signs:
  • Persistent postural instability and frequent falls.
  • Chronic anxiety, avoidance behaviors due to fear of falling or recurrent symptoms.
  • Significant functional impairment impacting daily activities.
• Atypical Presentations:
  • Persistent Postural-Perceptual Dizziness (PPPD): Chronic subjective dizziness, unsteadiness, or non-spinning vertigo, exacerbated by upright posture, head motion, or exposure to complex visual stimuli. Often follows an acute vestibular event.
  • Panic Disorder with Dizziness: Dizziness as a prominent symptom during panic attacks.
  • Malingering: Rare, but consider if symptoms are inconsistent or disproportionate.

Physical Examination

• General Assessment:
  • Vital signs: Orthostatic blood pressure and heart rate (measure after 5 minutes supine, then 1 and 3 minutes standing). Orthostatic hypotension defined as a drop in systolic BP ≥20 mmHg, or diastolic BP ≥10 mmHg, or an increase in HR ≥20 bpm within 3 minutes of standing.
  • General appearance, signs of distress, pallor, diaphoresis.
• Inspection:
  • Nystagmus: Observe eyes at rest, with gaze to sides, up/down, and during head movements.
    • Peripheral Nystagmus: Horizontal-torsional, fast phase beats away from the affected ear, typically resolves with visual fixation, unidirectional, often fatigable.
    • Central Nystagmus: Purely vertical or torsional, direction-changing, not suppressed by visual fixation, may be persistent.
  • Gait: Observe normal gait, tandem gait (heel-to-toe), Romberg test (feet together, eyes open then closed), sharpened Romberg (dominant foot heel to non-dominant foot toe, eyes open then closed).
    • Ataxia: Broad-based, unsteady gait suggests cerebellar or severe proprioceptive deficits.
    • Unilateral weakness/drift: Suggests focal neurological deficit.
• Special Tests:
  • HINTS Exam (for Acute Vestibular Syndrome - AVS): Crucial for differentiating central from peripheral causes in acute, persistent vertigo. Perform if patient has continuous vertigo for >24 hours, nystagmus, and gait instability.
    • H: Head Impulse Test (or Head Thrust Test): Rapidly turn patient's head ~10-20 degrees to one side while they fixate on your nose. If peripheral vestibular lesion, eyes will briefly move off target (saccadic correction, a "catch-up" saccade). Abnormal (positive) Head Impulse Test = Peripheral Vestibular Lesion. Normal (negative) Head Impulse Test = Central Lesion (danger sign).
    • I: Nystagmus: Observe for spontaneous nystagmus. Unidirectional nystagmus (Peripheral lesion). Direction-changing, purely vertical/torsional nystagmus (Central lesion).
    • TS: Test of Skew: Cover-uncover test. Cover one eye, then uncover. Repeat for other eye. Look for vertical realignment of eye. Skew deviation (one eye drifts up or down when covered, then realigns when uncovered) = Central Lesion.
    • HINTS Plus: Add "hearing loss" and "ear symptoms" (tinnitus, fullness). Sudden, unilateral hearing loss with vertigo suggests AICA stroke or labyrinthine infarction (central) rather than vestibular neuritis (peripheral).
    • Interpretation:
      • "Peripheral HINTS": Abnormal Head Impulse (corrective saccade), Unidirectional nystagmus (non-vertical, non-torsional), No Skew Deviation = Consistent with Peripheral Vertigo (e.g., vestibular neuritis).
      • "Central HINTS": Normal Head Impulse (no corrective saccade), Direction-changing, purely vertical/torsional nystagmus, OR Skew Deviation = Highly suspicious for Central Vertigo (e.g., stroke), even in presence of vertigo.
  • Dix-Hallpike Maneuver: For Benign Paroxysmal Positional Vertigo (BPPV).
    • Patient sits upright on exam table. Rotate head 45 degrees to one side. Rapidly recline patient to supine, with head extended ~20 degrees off the end of the table (supported). Observe eyes for nystagmus for up to 30 seconds.
    • Positive result: Latency of nystagmus (2-20 seconds), paroxysmal nystagmus that increases then fatigues (typically <60 seconds), subjective vertigo. Most common form (posterior canal BPPV) produces upbeating, torsional nystagmus towards the dependent ear. Repeat on other side.
  • Other Balance Tests:
    • Fukuda Step Test (Unterberger's Test): Patient marches in place with eyes closed for 30-60 seconds. Significant deviation (>30 degrees rotation or >0.5 meters displacement) suggests unilateral vestibular lesion (deviation towards affected side).
    • Dynamic Visual Acuity: Test visual acuity at rest, then during head movements. A decrease >2 lines during head movement suggests bilateral vestibular hypofunction.
    • Cranial Nerve Examination: To rule out central neurological deficits.
    • Cerebellar Tests: Finger-to-nose, heel-to-shin, rapid alternating movements.
  • Cardiac Auscultation: Murmurs (valvular disease), irregular rhythm (arrhythmia).
  • Carotid Auscultation: Bruits (carotid stenosis, though less direct for dizziness).

Diagnostic Approach

History Taking

• Key Questions:
  • "What do you mean by dizziness?": Crucial first step. Allow the patient to describe the sensation in their own words before suggesting terms. This distinguishes vertigo, presyncope, disequilibrium, or non-specific dizziness.
  • Onset: Sudden or gradual?
  • Duration: Seconds, minutes, hours, days, constant?
    • Seconds: BPPV, orthostatic hypotension, perilymphatic fistula.
    • Minutes to hours: Meniere's, vestibular migraine, TIA, panic attack.
    • Hours to days: Vestibular neuritis, labyrinthitis, stroke, MS exacerbation.
    • Constant (weeks to months): Bilateral vestibulopathy, PPPD, psychiatric, medication-induced, cerebellar degeneration.
  • Triggers: Specific head movements (BPPV)? Standing up (orthostatic hypotension)? Loud noises (Tullio phenomenon - superior canal dehiscence)? Visual stimuli (PPPD)? Stress/anxiety?
  • Associated Symptoms:
    • Auditory: Hearing loss, tinnitus, ear fullness (Meniere's, labyrinthitis, acoustic neuroma).
    • Neurological: Headache, diplopia, dysarthria, dysphagia, weakness, numbness, ataxia (central lesion, migraine).
    • Cardiovascular: Palpitations, chest pain, shortness of breath (cardiac causes).
    • Autonomic: Nausea, vomiting, sweating, pallor (common in vertigo and presyncope).
    • Psychiatric: Anxiety, panic, depersonalization (panic disorder, PPPD).
  • Exacerbating/Alleviating Factors: Lying down, movement, medications.
  • Past Medical History: Migraine, diabetes, hypertension, heart disease, stroke, anxiety/depression, head injury.
  • Medications: Review all current medications (prescription, OTC, supplements) for ototoxic effects, hypotensive effects, or CNS depression.
  • Impact on Daily Life: Falls, fear of falling, work/social limitations.
• Red Flags: Warning signs requiring urgent attention, suggesting a potentially serious underlying condition (e.g., stroke, myocardial infarction, intracranial hemorrhage, acute central lesion).
  • Sudden onset, severe headache (intracranial hemorrhage, stroke).
  • Focal neurological deficits: Diplopia, dysarthria, dysphagia, unilateral weakness/numbness, hemiparesis, severe truncal or limb ataxia (cerebellar/brainstem stroke, MS).
  • Altered consciousness or new-onset seizure.
  • Severe gait instability/ataxia disproportionate to vertigo.
  • Nystagmus that is purely vertical, purely torsional, direction-changing, or not suppressed by visual fixation (central lesion).
  • Abnormal (negative) Head Impulse Test in AVS (suggests central lesion).
  • New-onset unilateral hearing loss accompanying vertigo (HINTS Plus) (suggests AICA stroke or labyrinthine infarction).
  • Chest pain, palpitations, or other symptoms suggestive of acute cardiac event.
  • Recent head trauma.
  • Unexplained syncope.

Laboratory Tests

• First-Line: Guided by history and physical examination to rule out common systemic causes.
  • Complete Blood Count (CBC): To check for anemia (can cause presyncope/lightheadedness) or infection.
  • Electrolytes (BMP/CMP): Dehydration, hyponatremia, hyper/hypokalemia can contribute to dizziness.
  • Glucose: Hypoglycemia (common cause of lightheadedness), hyperglycemia.
  • Thyroid Function Tests (TSH): Hypo- or hyperthyroidism can cause various forms of dizziness.
  • Vitamin B12: Deficiency can lead to peripheral neuropathy and ataxia.
  • Electrocardiogram (ECG): To screen for arrhythmias (e.g., bradycardia, tachycardia, AV block), ischemic heart disease, or prolonged QT interval.
• Confirmatory (for specific suspected conditions):
  • Brain Natriuretic Peptide (BNP): If heart failure is suspected.
  • Troponin: If acute coronary syndrome is suspected.
  • Serologic tests: Syphilis, Lyme disease, autoimmune markers (if indicated by history).
  • Audiometry and Tympanometry: To assess hearing loss and middle ear function, especially with auditory symptoms (Meniere's, acoustic neuroma).
  • Vestibular Function Tests (VFTs):
    • Videonystagmography (VNG)/Electronystagmography (ENG): Measures eye movements to assess peripheral and central vestibular function. Includes caloric testing.
    • Rotary Chair Testing: Assesses the vestibulo-ocular reflex at varying frequencies. Useful for bilateral vestibulopathy.
    • Vestibular Evoked Myogenic Potentials (VEMPs): Measures saccule (cervical VEMP) and utricle (ocular VEMP) function. Useful for Meniere's, superior canal dehiscence.
    • Video Head Impulse Test (vHIT): Objective measurement of the vestibulo-ocular reflex for each semicircular canal.
• Monitoring: For chronic conditions that cause dizziness, e.g., blood glucose for diabetes, thyroid levels for thyroid disorders.

Imaging

• Recommended: Imaging is generally not indicated for isolated, clear-cut BPPV or typical vestibular neuritis. It is crucial when central causes are suspected or for persistent, unexplained dizziness with red flags.
  • Brain Magnetic Resonance Imaging (MRI) with contrast:
    • Indications: Red flags (focal neurological deficits, atypical nystagmus, severe ataxia), persistent dizziness without a clear peripheral cause, suspected central vestibular disorder (stroke, MS, tumor), new-onset unilateral hearing loss with vertigo.
    • Purpose: Gold standard for detecting brainstem or cerebellar stroke, MS plaques, tumors, or other central nervous system pathology. Can also visualize the inner ear.
  • Computed Tomography (CT) Head:
    • Indications: Acute setting for rapid exclusion of intracranial hemorrhage, large ischemic strokes, or skull fractures (e.g., after head trauma). Less sensitive than MRI for posterior fossa and brainstem lesions.
• Advanced:
  • Magnetic Resonance Angiography (MRA) or Computed Tomography Angiography (CTA):
    • Indications: If vertebrobasilar ischemia or dissection is suspected (e.g., with specific stroke symptoms).
  • Temporal Bone CT:
    • Indications: Suspected superior semicircular canal dehiscence or other inner ear bony abnormalities.
  • Inner Ear MRI (specific sequences):
    • Indications: To evaluate for endolymphatic hydrops in Meniere's disease or to detect subtle inner ear lesions.

Management

Management is highly dependent on the underlying cause of dizziness.

Acute Management

• Immediate:
  • Rule out life-threatening conditions: First priority is to exclude acute stroke, myocardial infarction, severe arrhythmias, intracranial hemorrhage.
  • Stabilize ABCs: Airway, Breathing, Circulation.
  • Fall Precautions: Ensure patient safety; assist with ambulation, bed rails up.
• Stabilization:
  • Symptomatic Relief: For severe vertigo, nausea, and vomiting.
    • Antiemetics:
      • Ondansetron 4-8 mg IV/PO every 4-8 hours PRN.
      • Promethazine 12.5-25 mg IV/IM/PO every 4-6 hours PRN.
    • Vestibular Suppressants (short-term use only, typically <48-72 hours):
      • Meclizine 25-50 mg PO every 6-8 hours PRN.
      • Dimenhydrinate 50 mg PO/IV every 4-6 hours PRN.
      • Benzodiazepines (e.g., lorazepam 0.5-1 mg PO/IV, diazepam 2-5 mg PO/IV): Use with caution due to sedation and risk of hindering vestibular compensation.
      • Rationale: These medications reduce the mismatch in vestibular input, but prolonged use can impede central compensation and prolong recovery in peripheral vestibular disorders.
• Emergency:
  • Suspected Stroke/TIA: Activate stroke protocol, rapid imaging (CT/MRI), neurological consultation.
  • Acute Cardiac Event: Manage according to ACLS guidelines, cardiology consultation.
  • Intracranial Hemorrhage: Neurosurgical consultation.
  • Severe Dehydration/Electrolyte Imbalance: IV fluid resuscitation, electrolyte correction.

Chronic Management

• Pharmacological:
  • Benign Paroxysmal Positional Vertigo (BPPV):
    • Medications are generally ineffective. The primary treatment is canalith repositioning maneuvers.
  • Vestibular Neuritis/Labyrinthitis:
    • Corticosteroids: Early administration (within 72 hours) may improve recovery of vestibular function. Prednisone 60 mg PO daily for 5 days, then taper over 5 days.
    • Antivirals (e.g., Valacyclovir): Role is controversial; not routinely recommended unless there's evidence of viral reactivation (e.g., herpes zoster oticus).
    • Vestibular Suppressants: For acute severe symptoms, limited to <3 days.
  • Meniere's Disease:
    • Diuretics: Hydrochlorothiazide 25 mg PO daily + Triamterene 37.5 mg PO daily.
    • Low-Salt Diet: <1500-2000 mg/day sodium.
    • Betahistine: Not FDA approved in the US, but widely used in Europe. Dose 8-16 mg PO TID. Evidence for efficacy is mixed.
    • Intratympanic Injections:
      • Corticosteroids (e.g., Dexamethasone): For acute attacks, can reduce vertigo and preserve hearing.
      • Gentamicin: Ablative therapy for severe, refractory Meniere's with poor hearing in the affected ear. Can cause permanent hearing loss.
  • Vestibular Migraine:
    • Acute Treatment: Triptans (e.g., sumatriptan 50-100 mg PO), NSAIDs, antiemetics.
    • Prophylaxis: Beta-blockers (e.g., propranolol 20-80 mg BID), Topiramate (25-100 mg daily), TCAs (e.g., nortriptyline 10-50 mg daily), CGRP monoclonal antibodies.
  • Persistent Postural-Perceptual Dizziness (PPPD):
    • SSRIs/SNRIs: Sertraline 25-100 mg daily, Escitalopram 5-20 mg daily, Venlafaxine 37.5-150 mg daily.
  • Orthostatic Hypotension:
    • Volume Expansion: Increased fluid and salt intake (if no contraindications like heart failure).
    • Fludrocortisone: 0.1-0.2 mg PO daily. Mineralocorticoid that increases sodium and water retention.
    • Midodrine: 2.5-10 mg PO TID. Alpha-1 adrenergic agonist, causes vasoconstriction. Avoid supine within 4 hours of dose.
    • Pyridostigmine: 30-60 mg PO TID. Acetylcholinesterase inhibitor, enhances ganglionic transmission.
• Non-pharmacological:
  • Vestibular Rehabilitation Therapy (VRT): Essential for most chronic vestibular disorders, especially after acute events like vestibular neuritis, and for PPPD. Tailored exercises designed to promote central nervous system compensation and adaptation. Includes:
    • Habituation exercises: Repeated exposure to movements that provoke dizziness.
    • Gaze stability exercises: Improve eye movement control (VOR exercises).
    • Balance training: Improve postural control and reduce falls.
    • Walking exercises.
  • Canalith Repositioning Maneuvers (CRM): For BPPV (e.g., Epley maneuver for posterior canal BPPV, Semont maneuver). Highly effective, with success rates >80-90% after one or two treatments.
  • Lifestyle Modifications:
    • Dietary: Low salt for Meniere's disease. Avoiding migraine triggers.
    • Hydration: Especially for orthostatic hypotension.
    • Avoidance of Triggers: Identify and avoid specific movements or situations that worsen dizziness.
    • Fall Prevention: Home safety assessment, remove trip hazards, adequate lighting, assistive devices (cane, walker).
  • Cognitive Behavioral Therapy (CBT): For anxiety, panic disorder, and PPPD, to address psychological contributors and fear avoidance behaviors.
  • Medication Review: Crucial, especially in the elderly, to discontinue or reduce doses of medications contributing to dizziness (e.g., sedatives, anticholinergics, multiple antihypertensives).
• Monitoring:
  • Regular follow-up to assess symptom severity, frequency, functional impact, and medication side effects.
  • Evaluate response to VRT.
  • Monitor for development of new symptoms or red flags.

Treatment Algorithms

• First-Line (Initial Approach):
  1. Rule out urgent/emergent causes: Use red flags and HINTS exam (for AVS). If central signs present, immediate imaging (MRI) and neurology consultation.
  2. Differentiate by symptom type: Vertigo, presyncope, disequilibrium, non-specific.
  3. Address most common causes first:
     • Vertigo (episodic, positional): Perform Dix-Hallpike. If positive, perform Epley/Semont maneuver (BPPV).
     • Vertigo (acute, sustained): If HINTS suggests peripheral (vestibular neuritis), short course of corticosteroids and vestibular suppressants, followed by VRT.
     • Presyncope (positional): Check orthostatic vitals. If positive, lifestyle measures, fluid/salt, medication review, consider fludrocortisone/midodrine.
     • Disequilibrium (chronic): VRT, medication review, address sensory deficits (vision, neuropathy).
     • Non-specific/Chronic (with anxiety): Consider PPPD, anxiety disorder. Refer for VRT, CBT, consider SSRIs/SNRIs.
• Second-Line (Alternative Treatments / Further Investigation):
  • If initial treatments fail or diagnosis is unclear, consider specialty referrals (otolaryngology, neurology, cardiology, psychiatry, physical therapy).
  • Perform specific vestibular function tests (VNG, vHIT, VEMPs).
  • Consider advanced imaging (e.g., MRA, specific inner ear MRI).
  • For Meniere's, if conservative measures fail, consider intratympanic steroids or gentamicin.
• Refractory Cases:
  • Re-evaluate diagnosis, consider less common etiologies or multifactorial causes.
  • Intensify VRT, consider specialized programs.
  • For Meniere's: Vestibular nerve section, labyrinthectomy (last resort, for unilateral disease with non-functional hearing).
  • For PPPD: Optimize medication management (SSRIs/SNRIs), combination of VRT and CBT.
  • Consider a multidisciplinary approach with specialists in vestibular disorders, neurology, otolaryngology, and psychology.

Complications

• Common:
  • Falls and Injuries: Especially in older adults and those with disequilibrium, leading to fractures, head trauma, and soft tissue injuries.
  • Anxiety and Depression: Chronic dizziness is highly associated with psychological distress, fear of falling, and avoidance behaviors.
  • Reduced Quality of Life: Impaired social participation, decreased independence, difficulty with work/daily activities.
  • Deconditioning: Due to avoidance of movement.
• Serious:
  • Stroke: As a cause or complication of falls related to dizziness.
  • Myocardial Infarction/Cardiac Arrhythmias: Can present with presyncope/dizziness.
  • Severe Trauma: From falls (e.g., subdural hematoma).
  • Polypharmacy complications: Due to medications prescribed for dizziness or other comorbidities.
• Long-term:
  • Persistent Imbalance and Gait Instability.
  • Chronic Pain: From injuries sustained during falls.
  • Social Isolation: Due to fear of experiencing dizziness in public.
  • Functional Dependence: Needing assistance with daily activities.

Prognosis

• Factors:
  • Underlying Etiology: Prognosis varies greatly. BPPV generally has an excellent prognosis with effective treatment. Vestibular neuritis typically resolves within weeks to months. Meniere's disease has a variable course with remissions and exacerbations. Central causes (e.g., stroke) depend on the severity and location of the lesion.
  • Age: Older adults often have a less favorable prognosis due to comorbidities, polypharmacy, and slower compensation.
  • Comorbidities: Concurrent neurological, cardiovascular, or psychiatric conditions can complicate recovery.
  • Timeliness of Diagnosis and Treatment: Early intervention for conditions like BPPV or vestibular neuritis improves outcomes.
  • Adherence to Therapy: Regular engagement in VRT is crucial for functional recovery.
  • Presence of Psychological Factors: Anxiety, depression, and somatization can prolong symptoms and impair recovery.
• Survival: Directly tied to the underlying cause. Dizziness itself is rarely fatal but can be a symptom of life-threatening conditions (e.g., stroke, severe arrhythmia).
• Quality of Life: Can be significantly impaired, but most patients show improvement with accurate diagnosis and appropriate management. Effective VRT and addressing psychological comorbidities are key to improving functional outcomes and quality of life. Resolution of symptoms or successful compensation allows many patients to return to normal activities.

Prevention

• Primary (Preventing Initial Occurrence):
  • Manage Chronic Diseases: Optimal control of hypertension, diabetes, hyperlipidemia to reduce risk of stroke and cardiovascular disease.
  • Regular Medication Review: Especially in older adults, to minimize polypharmacy and use of potentially dizzying medications.
  • Promote Healthy Lifestyle: Regular physical activity (improves balance and cardiovascular health), balanced diet, adequate hydration.
  • Fall Prevention Education: For at-risk populations.
• Secondary (Early Detection and Intervention):
  • Prompt Evaluation of Dizziness: Early, thorough evaluation to identify treatable causes (e.g., BPPV, vestibular neuritis, orthostatic hypotension) and prevent chronicity.
  • Timely Referral: To specialists (otolaryngology, neurology) when indicated for definitive diagnosis and treatment.
  • Early Vestibular Rehabilitation: Initiate VRT as soon as appropriate after an acute vestibular event to promote central compensation and prevent persistent symptoms.
• Tertiary (Preventing Complications):
  • Fall Prevention Strategies: Home safety modifications (remove rugs, improve lighting, grab bars), use of assistive devices, gait and balance training.
  • Psychological Support: Address anxiety, depression, and fear of falling through counseling, CBT, or pharmacotherapy.
  • Long-term VRT: For individuals with chronic vestibular deficits to maintain balance and prevent deconditioning.
  • Regular Follow-up: To monitor symptoms, assess treatment effectiveness, and adjust management plan.

Special Populations

• Pediatric:
  • Common Causes: Benign Paroxysmal Vertigo of Childhood, Vestibular Migraine (often without headache), BPPV (less common but can occur), Otitis Media (labyrinthitis), head trauma.
  • Atypical Presentation: Children may struggle to describe dizziness clearly, sometimes presenting as clumsiness, irritability, or fear of movement.
  • Evaluation: Requires careful history (from child and parents), thorough neurological exam. Imaging may be more frequently considered to rule out central causes.
• Geriatric:
  • High Prevalence: Dizziness is extremely common and often multifactorial.
  • Common Causes: Polypharmacy, orthostatic hypotension, bilateral vestibulopathy (age-related degeneration), BPPV, cardiovascular disease, central causes (stroke, neurodegeneration), sensory deficits (vision, proprioception), anxiety.
  • Increased Risk of Falls: Leading to significant morbidity and mortality.
  • Evaluation: Comprehensive assessment of all contributing factors, including detailed medication review, orthostatic vital signs, sensory testing, gait and balance assessment.
  • Management: Focus on medication reduction, targeted treatment of specific causes, aggressive fall prevention, and VRT.
• Pregnancy:
  • Common Causes: Physiologic changes (vasodilation, increased blood volume, iron deficiency anemia), hyperemesis gravidarum, vasovagal episodes. BPPV incidence may increase due to hormonal changes.
  • Management: Emphasize non-pharmacological approaches (hydration, small frequent meals, slow position changes). Medications should be carefully selected considering fetal safety (e.g., Meclizine is Category B). Epley maneuver is safe for BPPV.
• Comorbidities:
  • Cardiovascular Disease: Dizziness may be a symptom of underlying cardiac pathology (arrhythmias, heart failure, valvular disease). Careful cardiac workup is necessary.
  • Diabetes: Can cause peripheral neuropathy, autonomic neuropathy (leading to orthostatic hypotension), or microvascular disease affecting the inner ear or brainstem.
  • Neurological Disorders (e.g., Parkinson's, Multiple Sclerosis): Dizziness can be a direct symptom of the disease or due to medications. Patients often have combined balance deficits.
  • Psychiatric Disorders (e.g., Anxiety, Depression): Dizziness can be a primary symptom, exacerbate other types of dizziness, or be a side effect of psychotropic medications. Integrated mental health support is crucial.

Clinical Pearls

• Diagnostic:
  • "What do you mean by dizziness?" is the single most important question. Patients rarely mean only one thing. Deconstruct the term into vertigo, presyncope, disequilibrium, or non-specific dizziness.
  • Timing is Key: The duration of symptoms (seconds, minutes, hours, days, constant) is a crucial differentiator for many common diagnoses.
  • HINTS Exam: Master the HINTS exam for acute vestibular syndrome to reliably distinguish central from peripheral causes, potentially avoiding unnecessary neuroimaging in peripheral cases and ensuring prompt imaging for central ones. Remember: "INFARCT" for central stroke mnemonic (Impulse Normal, Fast-phase Alternating or Direction-changing, Refixation on Cover Test, and often Cranial nerve involvement, Ataxia, and diplopia/dysarthria).
  • Dix-Hallpike is Gold Standard for BPPV: Don't forget to perform it if the history suggests positional vertigo.
  • Orthostatic Hypotension: Always check orthostatic vital signs, especially in the elderly or those on antihypertensives.
  • Red Flags: Never miss them. Any focal neurological deficit, severe headache, or atypical nystagmus warrants urgent investigation.
• Treatment:
  • Vestibular Suppressants (Meclizine, Benzos): Use sparingly and short-term (max 48-72 hours) in acute peripheral vertigo. Prolonged use hinders central compensation and prolongs recovery.
  • Vestibular Rehabilitation Therapy (VRT): This is the cornerstone of chronic dizziness management and recovery for most vestibular disorders. Refer early.
  • Epley Maneuver: Highly effective and curative for most posterior canal BPPV. Perform it yourself or refer to a therapist trained in CRM.
  • Medication Review: Critically evaluate all medications, especially in older patients. Polypharmacy is a leading cause of dizziness.
  • Address Psychological Factors: Anxiety, depression, and fear of falling often co-exist with or exacerbate dizziness. Treat them directly with CBT and/or pharmacotherapy.
• Pitfalls:
  • Misinterpreting Central Vertigo as Peripheral: Failure to recognize central red flags or a "normal" HINTS exam in AVS can delay stroke diagnosis.
  • Overuse of Vestibular Suppressants: Leads to prolonged symptoms and prevents recovery.
  • Missing BPPV: Failure to perform Dix-Hallpike for positional vertigo.
  • Ignoring Multifactorial Dizziness: Especially in the elderly, where multiple contributing factors are common.
  • Failing to Refer for VRT: Prolongs patient suffering and functional impairment.
  • Attributing all dizziness to "age" or "anxiety": Leads to missed treatable conditions.

Recent Updates

• Guidelines:
  • 2017 Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update) by the American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) reaffirmed the strong recommendation for Dix-Hallpike and canalith repositioning maneuvers as the primary diagnostic and treatment tools.
  • 2017 Clinical Practice Guideline: Vestibular Migraine by the Bárány Society and the International Headache Society (IHS) established diagnostic criteria for Vestibular Migraine, facilitating diagnosis and treatment.
  • 2023 Guidelines for Orthostatic Hypotension: The American Autonomic Society and the European Federation of Autonomic Societies updated consensus statements on diagnostic criteria and management.
• Evidence:
  • Persistent Postural-Perceptual Dizziness (PPPD): Increased recognition and understanding of PPPD as a distinct chronic functional vestibular disorder. The 2017 diagnostic criteria by the Bárány Society have significantly improved its diagnosis. Research continues to support the efficacy of SSRIs/SNRIs, VRT (especially habituation and balance training), and CBT.
  • Vestibular Neuritis: Ongoing research into the optimal timing and dosing of corticosteroids and the role of antiviral agents, with strong evidence supporting early steroid use.
  • Meniere's Disease: Debate continues regarding the efficacy of betahistine. Emerging research on personalized treatment approaches, including novel intratympanic therapies and endolymphatic sac decompression.
  • Role of AI in Vestibular Diagnosis: Explorations into AI-powered tools for analyzing nystagmus and other oculomotor patterns to aid in differentiating central vs. peripheral vertigo.
• Controversies:
  • Betahistine Efficacy: While widely used internationally for Meniere's disease, its effectiveness remains debated in large, well-designed clinical trials, particularly compared to placebo in the US and UK.
  • Antivirals in Vestibular Neuritis: The routine use of antivirals for vestibular neuritis remains controversial due to conflicting evidence regarding their added benefit beyond corticosteroids.
  • Optimal Duration of Vestibular Suppressants: While consensus is for short-term use, the exact maximum duration and criteria for withdrawal can sometimes vary in practice.

Key References

• Guidelines:
  • Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017;156(3_suppl):S1-S47.
  • Lempert T, Olesen J, Furman JM, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167-172. (Further updated by Bárány Society and IHS in 2017).
  • Staab JP, Eckhardt-Henn A, Horii A, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the Bárány Society and the International Headache Society. J Vestib Res. 2017;27(4):191-208.
  • Shepard NT, Telian SA. Practical Management of the Dizzy Patient. 2nd ed. Thieme; 2015.
• Studies:
  • Kattah JC, Talkad AV, Shaikh AG, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination to differentiate central from peripheral cause. Stroke. 2009;40(11):3504-3510.
  • Strupp M, Zingler VC, Arbusow D, et al. Methylprednisolone in acute vestibular neuritis: a randomized, double-blind, placebo-controlled trial. N Engl J Med. 2004;351(4):354-361.
• Reviews:
  • Kerber KA, Brown DL, Lisabeth LH, et al. Dizziness and vertigo in emergency department patients: a population-based study. Acad Emerg Med. 2008;15(10):893-900.
  • Bisdorff A. Dizziness: an overview. Handb Clin Neurol. 2016;137:1-8.